Product Substitution as a Way Forward in Avoiding Potentially Harmful Excipients in Neonates.

CONCLUSIONS: EOI-free formulations are available for a substantial number of products currently used in European neonates. Replacement of only the most frequently used products may spare almost half of neonates from unnecessary exposure to EOI.
PMID: 27099961 [PubMed - as supplied by publisher]

Source: Paediatric Drugs - April 20, 2016 Category: Pediatrics Authors: Nellis G, Metsvaht T, Varendi H, Lass J, Duncan J, Nunn AJ, Turner MA, Lutsar I Tags: Paediatr Drugs Source Type: research